Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00200369 · ClinicalTrials.gov registry record
Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-based Regimen
A clinical trial, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- 90
- Enrollment target
NCT00200369 is a clinical trial that has completed, run by Montefiore Medical Center. The registered enrollment target is 90 participants.
The verdict
NCT00200369 has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
The hypothesis of this study is that the level of adherence necessary to achieve HIV virologic suppression with a ritonavir boosted protease inhibitor regimen (i.e. lopinavir/ritonavir) is less than the 95% rate observed in the published literature with unboosted regimens.
Interventions
- DEVICE MEMS cap
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2004-05 |
| Est. Completion | 2006-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00200369
The ClinicalTrials.gov registry entry for NCT00200369 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MEMS cap is the first listed.
NCT00200369 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00200369 about?
NCT00200369 is a clinical study titled "Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-based Regimen". The hypothesis of this study is that the level of adherence necessary to achieve HIV virologic suppression with a ritonavir boosted protease inhibitor regimen (i.e. lopinavir/ritonavir) is less than the 95% rate observed in the published literature with unboosted regimens.
What is the current status of trial NCT00200369?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2004-05. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00200369?
The interventions under investigation include: MEMS cap (DEVICE).
Who is sponsoring clinical trial NCT00200369?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.